Drug Pipeline

Single antiplatelet therapy (SAPT) Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
3
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-20 NCT07587099
Single vs. Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Intervention…		 Recruitment opened
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-05-14 NCT07587099 Single vs. Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Intervention… Recruiting
Active Studies by Phase
Phase 4
1
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07496281 OPTIA-AF Trial: Rhythm-Guided Antithrombotic Strategy After AF Ablation Atrial Fibrillation (AF) Not Yet Recruiting
Not specified
NCT06535568 Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous… Coronary Disease Recruiting
NCT07587099 Single vs. Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Intervention… Coronary Heart Disease (CHD) Recruiting
Sponsors Running Single antiplatelet therapy (SAPT) Trials
Fondazione Ricerca e Innovazione Cardiovascolare ETS (1) Ewha Womans University Mokdong Hospital (1) Gan Lijun (1)
Disease Areas
Heart Disease (2) Coronary Artery Disease (2) Atrial Fibrillation (1)
Get alerts when Single antiplatelet therapy (SAPT) trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free